In conclusion, we have shown that inhibition of JAK2 facilitates an increased macrophage-mediated lymphoma cell depletion in vitro, with superior overall survival of hMB JAK2−/− transplanted NSG mice in vivo. The gene discussed is JAK2; the disease is lymphoma.